These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 10073700

  • 1. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
    de Gruijl TD, Bontkes HJ, Walboomers JM, Coursaget P, Stukart MJ, Dupuy C, Kueter E, Verheijen RH, Helmerhorst TJ, Duggan-Keen MF, Stern PL, Meijer CJ, Scheper RJ.
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
    [Abstract] [Full Text] [Related]

  • 2. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.
    Bontkes HJ, de Gruijl TD, Walboomers JM, Schiller JT, Dillner J, Helmerhorst TJ, Verheijen RH, Scheper RJ, Meijer CJ.
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():409-417. PubMed ID: 10073701
    [Abstract] [Full Text] [Related]

  • 3. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa.
    Marais D, Rose RC, Williamson AL.
    J Med Virol; 1997 Feb; 51(2):126-31. PubMed ID: 9021543
    [Abstract] [Full Text] [Related]

  • 4. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
    de Gruijl TD, Bontkes HJ, Walboomers JM, Schiller JT, Stukart MJ, Groot BS, Chabaud MM, Remmink AJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ.
    J Natl Cancer Inst; 1997 May 07; 89(9):630-8. PubMed ID: 9150187
    [Abstract] [Full Text] [Related]

  • 5. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan.
    Matsumoto K, Yoshikawa H, Yasugi T, Nakagawa S, Kawana K, Takeoka A, Yaegashi N, Iwasaka T, Kanazawa K, Taketani Y, Kanda T.
    J Med Virol; 2003 Mar 07; 69(3):441-6. PubMed ID: 12526056
    [Abstract] [Full Text] [Related]

  • 6. Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.
    Marais DJ, Rose RC, Lane C, Kay P, Nevin J, Denny L, Soeters R, Dehaeck CM, Williamson AL.
    J Med Virol; 2000 Apr 07; 60(4):403-10. PubMed ID: 10686023
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
    Clerici M, Merola M, Ferrario E, Trabattoni D, Villa ML, Stefanon B, Venzon DJ, Shearer GM, De Palo G, Clerici E.
    J Natl Cancer Inst; 1997 Feb 05; 89(3):245-50. PubMed ID: 9017005
    [Abstract] [Full Text] [Related]

  • 10. Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia.
    Bontkes HJ, de Gruijl TD, van den Muysenberg AJ, Verheijen RH, Stukart MJ, Meijer CJ, Scheper RJ, Stacey SN, Duggan-Keen MF, Stern PL, Man S, Borysiewicz LK, Walboomers JM.
    Int J Cancer; 2000 Oct 01; 88(1):92-8. PubMed ID: 10962445
    [Abstract] [Full Text] [Related]

  • 11. Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls.
    Luxton JC, Rose RC, Coletart T, Wilson P, Shepherd PS.
    J Gen Virol; 1997 Apr 01; 78 ( Pt 4)():917-23. PubMed ID: 9129666
    [Abstract] [Full Text] [Related]

  • 12. Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study.
    de Gruijl TD, Bontkes HJ, Walboomers JM, Stukart MJ, Doekhie FS, Remmink AJ, Helmerhorst TJ, Verheijen RH, Duggan-Keen MF, Stern PL, Meijer CJ, Scheper RJ.
    Cancer Res; 1998 Apr 15; 58(8):1700-6. PubMed ID: 9563486
    [Abstract] [Full Text] [Related]

  • 13. T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection.
    de Gruijl TD, Bontkes HJ, Stukart MJ, Walboomers JM, Remmink AJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ.
    J Gen Virol; 1996 Sep 15; 77 ( Pt 9)():2183-91. PubMed ID: 8811018
    [Abstract] [Full Text] [Related]

  • 14. Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles.
    Odunsi K, Terry G, Ho L, Bell J, Cuzick J, Ganesan TS.
    Int J Cancer; 1996 Sep 04; 67(5):595-602. PubMed ID: 8782644
    [Abstract] [Full Text] [Related]

  • 15. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
    Yang R, Wheeler CM, Chen X, Uematsu S, Takeda K, Akira S, Pastrana DV, Viscidi RP, Roden RB.
    J Virol; 2005 Jun 04; 79(11):6741-50. PubMed ID: 15890912
    [Abstract] [Full Text] [Related]

  • 16. Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasia.
    Shepherd PS, Rowe AJ, Cridland JC, Coletart T, Wilson P, Luxton JC.
    J Gen Virol; 1996 Apr 04; 77 ( Pt 4)():593-602. PubMed ID: 8627247
    [Abstract] [Full Text] [Related]

  • 17. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
    Jin Y, Choi JW, Kim HJ, Eddouzi J, Kim SC, Ju W, Kim YH, Kim HJ.
    Cancer Med; 2018 Nov 04; 7(11):5655-5664. PubMed ID: 30353680
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.
    Yang W, Song Y, Lu YL, Sun JZ, Wang HW.
    Immunology; 2013 Aug 04; 139(4):513-22. PubMed ID: 23521696
    [Abstract] [Full Text] [Related]

  • 19. Evidence for at least two distinct groups of humoral immune reactions to papillomavirus antigens in women with squamous intraepithelial lesions.
    Strickler HD, Schiffman MH, Eklund C, Glass AG, Scott DR, Sherman ME, Wacholder S, Kurman RJ, Manos MM, Schiller JT, Dillner J.
    Cancer Epidemiol Biomarkers Prev; 1997 Mar 04; 6(3):183-8. PubMed ID: 9138661
    [Abstract] [Full Text] [Related]

  • 20. Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions.
    Sasagawa T, Inoue M, Lehtinen M, Zhang W, Gschmeissner SE, Hajibagheri MA, Finch J, Crawford L.
    Clin Diagn Lab Immunol; 1996 Jul 04; 3(4):403-10. PubMed ID: 8807204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.